• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » research_updates

Articles Tagged with ''research_updates''

Parent-Focused Therapy Outperforms Conjoint Therapy for Anorexia

September 1, 2016
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Bret A. Moore, PsyD, ABPP
Few disorders frustrate clinicians as much as anorexia nervosa (AN). In the June 2015 issue of TCPR, we interviewed James Lock, who guided us through one of the few effective AN treatments, family-based therapy (FBT). In FBT, a family therapist works with the entire family to come up with a weight restoration plan for the patient.
Read More

Citalopram Safety Warning Has Serious Consequences for VA Patients

July 25, 2016
Bret A. Moore, PsyD, ABPP
...
Read More

N-acetylcysteine Shows Promise for Skin-Picking Disorder

July 25, 2016
Bret A. Moore, PsyD, ABPP
...
Read More

Atomoxetine Does Not Increase Risk of Suicide Compared to Stimulants

July 1, 2016
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Bret A. Moore, PsyD, ABPP
Atomoxetine was not originally included in that rogue’s gallery of medications, but since the drug was originally developed as an antidepressant, the FDA later reviewed its safety data. A post-hoc meta-analysis of placebo-controlled trials revealed an increased risk of suicidal thinking, and so atomoxetine was also slapped with a black box warning.
Read More
RESEARCH UPDATE

Psychedelic Mushrooms May Help Treatment Resistant Depression

June 1, 2016
Bret A. Moore, PsyD, ABPP
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Bret A. Moore, PsyD, ABPP

Board-Certified Clinical Psychologist, San Antonio, TX

Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Psilocybin, a naturally occurring and psychedelic compound of the Psilocybe species of mushrooms, has garnered the most attention.
Psilocybin is essentially a serotonin 2A agonist. Theoretically, this action should mediate depressive symptoms, but we don’t know for sure because no available antidepressants are direct agonists of this receptor. Researchers from the United Kingdom set out to see if this is indeed the case.
Read More
RESEARCH UPDATE

Good News for Smoking Cessation Drugs: Not as Scary as Once Thought

June 1, 2016
Bret A. Moore, PsyD, ABPP
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Bret A. Moore, PsyD, ABPP                                    

Board-Certified Clinical Psychologist, San Antonio, TX.                                       

Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Both varenicline (Chantix) and bupropion (Zyban) are effective anti-smoking agents, but over the years we’ve heard about potential neuropsychiatric side effects, especially related to varenicline. These include depression, suicidal thoughts, psychosis, and nightmares.
Read More

Second-Generation Antipsychotics Do Not Raise Risk of Major Malformations

May 13, 2016
Bret A. Moore, PsyD, ABPP
...
Read More

Meds for ADHD Not Working? Add CBT

May 1, 2016
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Bret A. Moore, PsyD, ABPP. Board-Certified Clinical Psychologist, San Antonio, TX. Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Medication is an effective and necessary treatment for many adolescents struggling with ADHD. Unfortunately, even when patients and parents report significant relief from meds, symptoms persist, which can lead to ongoing problems at school, at home, and with peers. That’s why psychosocial interventions are an important part of any treatment plan for adolescents with ADHD.
Read More

Risperidone Leads to Serious Metabolic Problems in Autistic Children

May 1, 2016
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Bret A. Moore, PsyD, ABPP. Board-Certified Clinical Psychologist, San Antonio, TX. Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The metabolic effects of atypical antipsychotics in children are well known, and carefully weighing the risk-benefit ratio of their use is a difficult ordeal for both parents and clinicians. The reality is that the use of these meds is necessary for some children, particularly those dealing with an autism spectrum disorder with serious behavioral problems.
Read More
RESEARCH UPDATE

When Physicians Become Addicted: How Well Do Treatment Programs Work?

May 1, 2016
Bret A. Moore, PsyD, ABPP
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Bret A. Moore, PsyD, ABPP. Board-Certified Clinical Psychologist, San Antonio, TX.

Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
When physicians are diagnosed with opioid or other drug dependence, they are required to receive treatment from special physician health programs (PHP) if they want to keep their medical licenses. Unlike treatment programs for the general population, PHPs do not use opiate agonists, such as methadone or buprenorphine.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 16 17 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2635946985.jpg
    General Psychiatry

    AI in Practice

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.